In this issue of Molecular Cell, Simon et al. (2019) demonstrate that phase separation of an engineered intrinsically disordered protein can be used to control in vitro translation via the formation of artificial ribonucleoprotein granules.
Copyright © 2019 Elsevier Inc. All rights reserved.